HIGH-DOSE TREATMENT WITH ANTIBIOTICS IN CYSTIC-FIBROSIS - A REAPPRAISAL WITH SPECIAL REFERENCE TO THE PHARMACOKINETICS OF BETA-LACTAMS AND NEW FLUOROQUINOLONES IN ADULT CF-PATIENTS

被引:26
作者
SORGEL, F
STEPHAN, U
WIESEMANN, HG
GOTTSCHALK, B
STEHR, C
REY, M
BOWING, HB
DOMINICK, HC
VONMALLINCKRODT, MG
机构
[1] UNIV ERLANGEN NURNBERG,DEPT PEDIAT,D-8520 ERLANGEN,FED REP GER
[2] UNIV MUNSTER,DEPT PEDIAT,D-4400 MUNSTER,FED REP GER
[3] UNIV ERLANGEN NURNBERG,INST FORENS TOXICOL,D-8520 ERLANGEN,FED REP GER
[4] INST BIOMED & PHARMACEUT RES,D-8500 NURNBERG,FED REP GER
关键词
D O I
10.1007/BF01647751
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:385 / 396
页数:12
相关论文
共 92 条
[1]  
AHRENS T, 1979, DRUGS EXP CLIN RES, V5, P61
[2]   RENAL-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
ALADJEM, M ;
LOTAN, D ;
BOICHIS, H ;
ORDA, S ;
KATZNELSON, D .
NEPHRON, 1983, 34 (02) :84-86
[3]  
ALVAN G, 1984, CYSTIC FIBROSIS HORI
[4]   MEZLOCILLIN DOSE DEPENDENT ELIMINATION KINETICS IN RENAL IMPAIRMENT [J].
ARONOFF, GR ;
SLOAN, RS ;
STANISH, RA ;
FINEBERG, NS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :505-509
[5]   DIFFERENCE IN RENAL HANDLING OF CEFSULODIN BETWEEN PATIENTS WITH CYSTIC-FIBROSIS AND NORMAL SUBJECTS [J].
ARVIDSSON, A ;
ALVAN, G ;
STRANDVIK, B .
ACTA PAEDIATRICA SCANDINAVICA, 1983, 72 (02) :293-294
[6]   AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
BLOUIN, RA ;
GRIFFEN, WO ;
RECORD, KE ;
BELL, RM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04) :519-522
[7]   INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
EDWARDS, WAD ;
DELLINGER, EP ;
SIMONOWITZ, DA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) :643-647
[8]  
BAUER LA, 1983, CLIN PHARMACY, V2, P262
[9]   CIMETIDINE CLEARANCE IN THE OBESE [J].
BAUER, LA ;
WAREINGTRAN, C ;
EDWARDS, WAD ;
RAISYS, V ;
FERRERI, L ;
JACK, R ;
DELLINGER, EP ;
SIMONOWITZ, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (04) :425-430
[10]  
BENDER SW, 1986, INFECTION, V14, P23